As of 2025-10-23, the Relative Valuation of Summit Therapeutics Inc (SMMT) is (0.61) USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.16 USD, the upside of Summit Therapeutics Inc based on Relative Valuation is -103.2%.
The range of the Relative Valuation is (0.49) - (0.73) USD.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 2.0x - 3.1x | 2.6x |
| Fair Price | (0.49) - (0.73) | (0.61) |
| Upside | -102.5% - -103.8% | -103.2% |
| Date | P/E |